The relationship of plasminogen activators and oncogenes to tumour invasion
- PMID: 2155139
The relationship of plasminogen activators and oncogenes to tumour invasion
Abstract
Accruing evidence suggests an association between increased activity of plasminogen activators and transformed cells, and urokinase activity with tumour aggressiveness. The PIP2 pathway seems to provide a link between oncogene-associated transformation, cellular proliferation, plasminogen-activator expression and tumour invasion and metastasis.
Similar articles
-
[Role of plasminogen activators in cancer dissemination. Clinical perspectives].Medicina (B Aires). 1992;52(3):252-6. Medicina (B Aires). 1992. PMID: 1342692 Review. Spanish. No abstract available.
-
Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).Prostate. 2004 May 1;59(2):167-76. doi: 10.1002/pros.20009. Prostate. 2004. PMID: 15042617
-
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.Oncogene. 1999 Jul 22;18(29):4237-46. doi: 10.1038/sj.onc.1202799. Oncogene. 1999. PMID: 10435636
-
The role of plasminogen activator receptor in cancer invasion and dormancy.Medicina (B Aires). 1999;59(5 Pt 2):547-52. Medicina (B Aires). 1999. PMID: 10684157
-
Plasmin/plasminogen system in colorectal cancer.World J Surg. 2002 Jul;26(7):767-71. doi: 10.1007/s00268-002-4050-8. Epub 2002 Apr 30. World J Surg. 2002. PMID: 11965442 Review.
Cited by
-
Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.Br J Cancer. 1995 Feb;71(2):393-6. doi: 10.1038/bjc.1995.80. Br J Cancer. 1995. PMID: 7841059 Free PMC article.